Current Liabilities
Amgen·Balance Sheet Statement·7 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current liabilities | $21.5B | $20.3B | $23.1B | $23.0B | $20.5B | $21.8B | $25.5B | $25.0B |
| Accrued expenses | $13.7B | $14.6B | $17.6B | $17.2B | $15.0B | $16.8B | $18.5B | $16.6B |
| Other Commercial Liabilities | $13.7B | $14.6B | $17.6B | $17.2B | $15.0B | $16.8B | $18.5B | $16.6B |
| Accrued Liabilities, Current | $13.7B | $14.6B | $17.6B | $17.2B | $15.0B | $16.8B | $18.5B | $16.6B |
| Current portion of long-term debt | $5.5B | $3.5B | $3.6B | $3.4B | $2.4B | $2.2B | $4.6B | $5.4B |
| Accounts payable | $2.3B | $2.1B | $1.9B | $2.4B | $3.0B | $2.8B | $2.4B | $2.9B |
| Derivative Liabilities - Fair Value | $1.0B | $886.0M | $1.0B | $880.0M | $1.0B | $904.0M | $827.0M | $792.0M |